Sangamo Therapeutics
SGMO
#10604
Rank
NZ$54.68 M
Marketcap
NZ$0.13
Share price
0.00%
Change (1 day)
-85.39%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2023 (TTM): NZ-$2.36

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.68. In 2022 the company made an earnings per share (EPS) of NZ-$2.23 a decrease over its 2021 EPS that were of NZ-$2.21.

EPS history for Sangamo Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$2.365.7%
2022NZ-$2.230.81%
2021NZ-$2.2133.33%
2020NZ-$1.666.9%
2019NZ-$1.5522.54%
2018NZ-$1.271.43%
2017NZ-$1.25-31.37%
2016NZ-$1.8275.86%
2015NZ-$1.0348.72%
2014NZ-$0.70-17.02%
2013NZ-$0.849.3%
2012NZ-$0.77-39.44%
2011NZ-$1.2729.09%
2010NZ-$0.9822.22%
2009NZ-$0.80-25%
2008NZ-$1.073.45%
2007NZ-$1.035.45%
2006NZ-$0.9810%
2005NZ-$0.89-9.09%
2004NZ-$0.9830.95%
2003NZ-$0.75-65.29%
2002NZ-$2.1615.24%
2001NZ-$1.873.96%
2000NZ-$1.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.91-1,857.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.00-4,673.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$4.21-721.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ-$2.27 234.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ-$5.53 715.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.77-361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$35.33-5,313.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ-$0.16-76.32%๐Ÿ‡บ๐Ÿ‡ธ USA